US Edition
New blood test could stop melanoma patients becoming resistant to treatment
Summary by manchester.ac.uk
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
New blood test could stop melanoma patients becoming resistant to treatment
The Christie NHS Foundation Trust together with the Cancer Research UK National Biomarker Centre and The University of Manchester has developed a new blood test that can tell doctors precisely how active a patient’s cancer is at any moment in time. By carefully monitoring the level of cancer activity in the blood, doctors can identify the best time to start and stop the drugs to give treatment breaks, which it is hoped will prevent resistance t…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
